Myriad Pharmaceuticals, Inc. to Host Initial Public Conference Call On July 1, 2009

SALT LAKE CITY, June 29, 2009 (GLOBE NEWSWIRE) -- Myriad Pharmaceuticals, Inc. (Nasdaq:MYRXV) today announced that it will hold a live webcast on Wednesday, July 1, 2009 at 10:00 AM EDT. Adrian Hobden, Ph.D., the Company's President and Chief Executive Officer will provide an overview of the Company's corporate strategy and pipeline of novel small molecule drug candidates to treat severe medical conditions, including cancer and HIV infection.